Live Breaking News & Updates on Insider activity at rhythm pharmaceuticals

Stay updated with breaking news from Insider activity at rhythm pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rhythm Pharmaceuticals (NASDAQ:RYTM) Releases Earnings Results, Misses Estimates By $0.01 EPS

Rhythm Pharmaceuticals (NASDAQ:RYTM) Releases Earnings Results, Misses Estimates By $0.01 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Yann-mazabraud , Davidp-meeker , Rhythm-pharmaceuticals-inc , Needham-company , Insider-activity-at-rhythm-pharmaceuticals , Goldman-sachs-group , Wells-fargo-company , Earnings-history-for-rhythm-pharmaceuticals , Rhythm-pharmaceuticals-stock-performance , Securities-exchange-commission

Rhythm Pharmaceuticals (NASDAQ:RYTM) Announces Earnings Results

Rhythm Pharmaceuticals (NASDAQ:RYTM) Announces Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Florida , United-states , Joseph-shulman , Hunterc-smith , Nasdaq , Institutional-trading-of-rhythm-pharmaceuticals , Asset-management-americas-inc , Insider-activity-at-rhythm-pharmaceuticals , Earnings-history-for-rhythm-pharmaceuticals , Rhythm-pharmaceuticals , Rhythm-pharmaceuticals-price-performance , News-ratings-for-rhythm-pharmaceuticals-daily

Rhythm Pharmaceuticals' (RYTM) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities research analysts have also recently issued reports on RYTM. Wells Fargo & […] ....

China , Recursos-ltda , Jennifer-kayden-lee , Joseph-shulman , Rhythm-pharmaceuticals , Wells-fargo-company , China-universal-asset-management-co , Analyst-recommendations-for-rhythm-pharmaceuticals , Needham-company , Institutional-trading-of-rhythm-pharmaceuticals , News-ratings-for-rhythm-pharmaceuticals-daily , Goldman-sachs-group

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Down to $47.20

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $47.20, but opened at $45.74. Rhythm Pharmaceuticals shares last traded at $46.02, with a volume of 87,390 shares trading hands. Wall Street Analysts Forecast Growth A number of research firms have […] ....

China , Chicago , Illinois , United-states , Hunterc-smith , Jennifer-kayden-lee , Rhythm-pharmaceuticals-trading , Rhythm-pharmaceuticals-inc , Goldman-sachs-group , Rhythm-pharmaceuticals-company-profile , Allspring-global-investments-holdings , Life-insurance-co

Rhythm Pharmaceuticals (NASDAQ:RYTM) Shares Down 10.2%

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) dropped 10.2% during mid-day trading on Thursday . The company traded as low as $16.43 and last traded at $16.64. Approximately 490,412 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 645,541 shares. The stock had previously closed at $18.52. Analyst […] ....

Hunterc-smith , Williamt-roberts , Dekabank-deutsche-girozentrale , Hermes-inc , Rice-hall-james-associates , Canaccord-genuity-group , Needham-company , Ghost-tree-capital , Institutional-trading-of-rhythm-pharmaceuticals , Rhythm-pharmaceuticals-inc , Insider-activity-at-rhythm-pharmaceuticals , Morgan-stanley